课题基金 / 基金详情

项目摘要

项目成果

Malek Kamoun的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This proposal is a continuation of our previous studies aimed at analyzing the properties and the function of the CD2/E-receptor pathway of human T cell activation. Our interest is to study the structure-function relationship of CD2 and to define and better understand the molecular and physiological events associated with the triggering of CD2 receptors by mitogens and monoclonal antibodies. We will examine 1) the phosphorylation of CD2 molecules on human T cells in the presence of regimens known to affect cell activation, including the triggering by mitogenic combinations of anti-CD2 monoclonal antibodies. We will analyze the phosphoamino acid composition of 32P CD2. 2) Furthermore, we will pursue the analysis and functional testing of CD2 cDNA clones using DNA transfection techniques. We will attempt to reconstitute an active CD2 receptor by DNA transfer in CD2-negative lymphoid T cell lines. We already have demonstrated that a full-length CD2 cDNA clone can be transiently expressed in Cos-7 cells, using the pcEXV-CD2 vector containing the SV40 promoter. Surface CD2 molecules of transfectant cells expressed the adhesion sites as well as activation sites defined by monoclonal antibodies. We will attempt to isolate stable lymphoid cell line transfectants expressing high levels of cell surface CD2 using the expression vector pBC12/CMV/CD2 containing the human cytomegalovirus immediate-early promoter as well as other expression vectors. Positive selection for stable transfectant will be achieved by co- transfectant plasmids (pcEXV-Neo) containing the mammalian selectable marker neo. The generation of deletion mutants of CD2 cDNA using Exonuclease III digestion or site specific mutagenesis will allow us to examine specific amino acid sequences necessary for the proper functioning of CD2, in particular, the ligand binding site (T111), the activation site (T112/T113), and the role of particular amino acids in the cytoplasmic region, including those modified by phosphorylation, as well as the unusual clusters of basic residues and prolines. Many described roles of CD2 in T cell activation and differentiation make the study of CD2 structure-function extremely important for understanding and potentially manipulating the immune response.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Diminished tyrosine protein kinase activity in T cells unresponsive to TCR stimulation.
对 TCR 刺激无反应的 T 细胞中酪氨酸蛋白激酶活性降低。
DOI: 10.1002/jlb.55.3.289
发表时间: 1994
期刊: Journal of leukocyte biology
影响因子: 5.5
作者: [Tsygankov,AY, Kim,HW, Pratt,JC, Spana,C, Class,K, Gaulton,GN, Kamoun,M, Bolen,JB]
通讯作者: Bolen,JB
Down regulation of IL 2 mRNA by antibody to the 50-kd protein associated with E receptors on human T lymphocyte.
与人 T 淋巴细胞 E 受体相关的 50-kd 蛋白抗体下调 IL 2 mRNA。
DOI: --
发表时间: 1986
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Tadmori,W, Kant,JA, Kamoun,M]
通讯作者: Kamoun,M
Interleukin-4 differentially regulates interleukin-2-mediated and CD2-mediated induction of human lymphokine-activated killer effectors.
Interleukin-4 差异性地调节 IL-2 介导和 CD2 介导的人淋巴因子激活杀伤效应器的诱导。
DOI: 10.1002/eji.1830221116
发表时间: 1992
期刊: European journal of immunology
影响因子: 5.4
作者: [Robinet,E, Kamoun,M, Farace,F, Chouaib,S]
通讯作者: Chouaib,S
Analysis of CD2 and TCR-beta gene expression in Jurkat cell mutants suggests a cis regulation of gene transcription.
Jurkat 细胞突变体中 CD2 和 TCR-β 基因表达的分析表明基因转录存在顺式调控。
DOI: --
发表时间: 1995
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Kamoun,M, Woods,JS, Sano,N, Makni,H, Smith,R, deLau,WB, vanOers,A, Wotton,D, Owen,MJ, Hashimoto,Y, Clevers,HC]
通讯作者: Clevers,HC
HLA Immunogenetics and kidney allograft outcomes
  • 批准号:
    10566338
  • 项目类别:
  • 资助金额:
    $85.26万
  • 财政年份:
    2022
  • 负责人:
    Malek Kamoun
  • 依托单位:
Core--Immunology
  • 批准号:
    6354593
  • 项目类别:
  • 资助金额:
    $23.33万
  • 财政年份:
    2000
  • 负责人:
    Malek Kamoun
  • 依托单位:
Core--Immunology
  • 批准号:
    6228099
  • 项目类别:
  • 资助金额:
    $23.33万
  • 财政年份:
    1999
  • 负责人:
    Malek Kamoun
  • 依托单位:
BIOLOGY OF THE E-RECEPTOR ASSOCIATED ANTIGEN
  • 批准号:
    3130638
  • 项目类别:
  • 资助金额:
    $12.31万
  • 财政年份:
    1984
  • 负责人:
    Malek Kamoun
  • 依托单位:
海外基金